Published inClinical, Cosmetic and Investigational Dermatology,the open-label clinical trial evaluated the efficacy and safety of the serum in 42 healthy adult male and female subjects over the course of 90 days. Self- and dermatological assessment were used, along with TrichoScan, an instrument and software-based tool, to assess hair growth.
Related: Sabinsa: Focus on Sustainability and Social Responsibility The New Beauty Sabinsa Ingredients Receive Non-GMO Verification
The results: Significantly reduced hair fall and thinning, and an improvement in hair growth rate. The dermatologist found a 57% reduction in hair breakage and an 81% reduction in hair fall; TrichoScan analysis revealed significant improvement in hair density and growth. No adverse events were reported, and scalp conditions noted during the baseline visits—including itching, dryness, and dandruff—were resolved after application of the product.“The effects of hair loss can be emotionally consequential,” said Sabinsa Founder and Chairman Dr. Muhammed Majeed in the press release. “Though herbs and more recently herbal extracts have been used in hair care, this combination of ingredients offer a synergistic activity, as each of them have a different mechanism for protecting and nourishing hair follicles.”
The product is currently licensed to Johara Cosmetics, but the press release notes that Sabinsa plans to open the license to customers worldwide under the trademark AMIFERA.
